Archive for the ‘Alzheimer's Disease’ Category

Pfizer-Backed Experimental Drug for Alzheimer’s Fails in Trial

Friday, March 12th, 2010

Bad news on the Alzheimer’s drug development front: Pfizer and Medivation announced negative results from a large late-stage trial of Dimebon, thought to be a promising treatment more potent than those currently on the market.Dimebon, you may remember, got its start a quarter-century ago as a Russian cold medicine that Pfizer plunked down $225 million for licensing rights in 2008. The deal also included potential milestone payments of as much as $500 million.The drug, considered to be the compound furthest along of those in development to treat Alzheimer’s, had shown impressive effects in a trial 183 Russian patients. But scientists in the field have questioned the small size of the study and the whether the findings could be applied to other populations since it was conducte…

More: continued here

An case of CADASIL? Or something else?

Friday, March 12th, 2010

Older Adult’s Acceptability Ratings of Treatments for Verbal Agitation in Persons With Dementia

Friday, March 12th, 2010

Allon’s Phase 1 Trial Broadens Davunetide’s Intranasal Safety And Dose Range

Friday, March 12th, 2010

Technology And Positive Attitudes Improving Older People’s Lives

Friday, March 12th, 2010

Mediterranean Diet May Protect Aging Brains from Damage

Friday, March 12th, 2010

State Roundup: N.Y. Drug Pricing, Vermont Hospital Ads, Massachusetts Nursing Homes And Anti-Psychotics

Friday, March 12th, 2010

Review of Issue: Interventions and Diagnostics in Alzheimer’s Disease and Related Conditions

Friday, March 12th, 2010

Belly Fat in Middle Age Increases Alzheimer’s Risk

Friday, March 12th, 2010

Damaged Protein May ID Alzheimer’s in Healthy Adults

Friday, March 12th, 2010